Thursday, November 12, 2026

Banco Bilbao Vizcaya Argentaria Stock Impressive Drop 10% At Session Start On Wednesday, Underperforms Market

Banco Bilbao Vizcaya Argentaria Stock  Impressive Drop 10%  At Session Start On Wednesday, Underperforms Market

(VIANEWS) - Shares of Banco Bilbao Vizcaya Argentaria (NYSE: BBVA) dropped by a staggering 10.21% to $6.33 at 10:15 EST on Wednesday, after two sequential sessions in a row of gains. NYSE is rising 1.22% to $14,944.74, following the last session's upward trend. This seems, at the moment, an all-around bullish trend trading session today.

Banco Bilbao Vizcaya Argentaria's last close was $7.05, 5.87% under its 52-week high of $7.49.

About Banco Bilbao Vizcaya Argentaria

Banco Bilbao Vizcaya Argentaria, S.A., together with its subsidiaries, provides retail banking, wholesale banking, and asset management services. It offers current accounts; and demand, savings, overnight, time, term, and subordinated deposits. The company also provides loan products; deals in securities; and manages pension and investment funds. In addition, it offers credit cards; corporate and investment banking services; insurance products and services; and real estate services. The company provides its products through online and mobile channels. It operates in Spain, Mexico, South America, the United States, Turkey, Asia, and rest of Europe. Banco Bilbao Vizcaya Argentaria, S.A. was founded in 1857 and is headquartered in Bilbao, Spain.

Earnings Per Share

As for profitability, Banco Bilbao Vizcaya Argentaria has a trailing twelve months EPS of $0.69.

PE Ratio

Banco Bilbao Vizcaya Argentaria has a trailing twelve months price to earnings ratio of 9.23. Meaning, the purchaser of the share is investing $9.23 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.25%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Bilbao Vizcaya Argentaria's stock is considered to be overbought (>=80).

More news about Banco Bilbao Vizcaya Argentaria (BBVA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com